EDITOR’S NOTE: On May 20, NJ Cannabis Insider in collaboration with Advance Media New York hosts a digital enterprise networking occasion, that includes a few of New York state’s most outstanding trade leaders. Tickets are limited.
As extra states enable cannabis use, U.S. Sen. Robert Menendez desires to know what affect authorized marijuana as on their residents and budgets.
Toward that finish, Menendez on Thursday launched bipartisan laws to require a research of simply that for authorized medical and leisure marijuana.
Under the invoice, the U.S. Health and Human Services, Justice and Labor departments would be part of with state well being companies and have the National Academy of Sciences research authorized cannabis applications over the following 10 years.
Reports can be issued each two years on the impacts of authorized marijuana on state economies, well being, prison justice and employment. The research additionally would give attention to how a lot cash the newly authorized cannabis companies are being into state and native coffers, and what these funds are being spent on.
And the research would take a look at the medicinal advantages of marijuana, if any, together with whether or not it has decreased using opioids or different painkillers.
The outcomes can be submitted to Congress.
“As more and more states legalize and regulate marijuana, we must take a thorough examination at how different laws and policies in different states have been implemented, what works, what doesn’t, and what can be replicated elsewhere,” Menendez stated. “Having this data at our fingertips and making it available to the public will help drive public policy decisions and dispel any misconceptions about marijuana legalization.”
The invoice was co-sponsored by U.S. Sen. Rand Paul, R-Ky. Similar laws was launched within the House by Reps. Sylvia Garcia, D-Texas, and Don Young. R-Alaska.
All however six states, together with New Jersey, have both legalized or decriminalized cannabis for both medical or leisure use.
Advocates of legalizing marijuana, together with NORML, the National Cannabis Industry Association, and the Minority Cannabis Business Association, have endorsed the invoice.
“The Marijuana Data Collection Act will ensure that federal discussions and policies specific to cannabis policy are based upon the best, most reliable, and recent evidence available moving forward,” NORML Political Director Justin Strekal stated. “To be clear, this is not a marijuana reform bill, it is a data bill about what is happening around the country.”
Our journalism wants your help. Please subscribe in the present day to NJ.com.